Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Def improving slowly. Holding breath for some sustained momentum, but with an oxygen mask nearby :)
Imagination is important, therefore the imaginariness of things is important.
You still live in NYC? Been in the west village for last twelve years, imagine myself far away on a daily basis. City really breaking my balls lately.
Tricky questions. I’d start a bit deeper: does money actually exist?
Good points. Share issuance definitely makes sense if a future buyback is in the cards.
Agree that share issuance would be a short-term disaster for the PPS.
But I think company will try to refinance/raise more debt, as opposed to equity, for liquidity issues. Most of the share issuance was for acquisitions, not liquidity. We shall see.
Don’t think 1.2B OS has been confirmed. News sources still have 1.01B
Can you please provide a link for this?
Hunch, I’m with you. But Cam should keep his mouth shut for a long while.
Not almost, it is comical.
Hm, interesting hypothetical.
Free-fall continues
What brokerage you use?
Tough couple weeks in ACBland
Solid commentary
Whoa! Don’t get too seriously
Yes exactly. Article is worthless.
This article is uniquely low on substance, no analysis. Just a recap of the recent past to current.
Trying to be objective here. If black eye is too strong, self-inflicted wound? These projection hits/misses are important to maintain confidence in future projections. This stock’s under enough damn pressure as it is.
That being said, they didn’t miss by much, and we have to give them a chance to explain.
But I agree, the big picture is the company’s doing very well. I think the market will appreciate the numbers after full digestion.
Depends on the perception of the market, and you can’t judge from the first day’s trading.
Miss is a black eye, but numbers are good.
We’ll see.
Let’s see. The next report is out mid-November, could be strong on all fronts.
Was really excited for possible guidance for next quarter and beyond. Excitement’s been tamped down a bit with this guidance mishap. Hopefully they have a good explanation for the miss that provides some confidence.
They better be careful with that guidance.
Point is it’s an unnecessary self-inflicted wound. Why make such a dumb error? Especially when you give yourself a 7M margin of error to work with. Just dumb.
But agree on not over-dramatizing it.
Revenue is good imo, and 11.7M loss is tightening up. They should be “adjusted” positive for current quarter.
But the stupid guidance.
Unreal.
Lmao
What you thinking?
ROFL
If you’re referring to APHA, hard to say. Apparently profitability is a flexible concept for them.
https://www.marketwatch.com/amp/story/guid/13BA7A94-BA0F-11E9-96E5-91DC997FBC41
Your CEO got ran out of another company for futzing around with “profitability”.
In any case, if APHA was profitable, it wasn’t as a result of selling cannabis. That’s why its SP is suppressed and its market cap is small. Maybe they should consider jumping sectors and give up on the whole cannabis thing. Lol.
We’ll see about ACB’s profitability. You’re all speculation. Since ACB is by far the biggest producer, people can draw their own conclusions about the future profitability.
Impairment value, meh. Doesn’t affect sales or profit, the real SP drivers.
The issue with smaller producers, Apha, Tilray, Cronos, is they don’t produce or sell much cannabis. Apha had great revenue, but 77 percent of it was from a pharmaceutical sales company they acquired. That’s why they couldn’t maintain the nice pop from the news. Market knows their growth is limited.
The cannabis companies that appreciate in value will come from companies who produce and sell the most cannabis.
We’ll see what the smaller producers do in the coming quarters.
Gross value
These fighters are legit stoned, so they’re def moving a little slower than normal.
I cannot. Was generally referring to a company beating its guidance, should’ve been more clear.
But hoping your three-point scenario happens here :)
Companies do underestimate earnings and then beat them. If you don’t think they do so intentionally, I respect your right to an opinion.
That’s fair. I believe they’ve disclosed their use of “adjusted”, but agree they should’ve spelled it out in the Q3 PR.
What makes me most skeptical is the “cannabis operations” part, which implies they’re compartmentalizing for EBITDA purposes.
On other hand, maybe they’re slow-rolling a surprise beat or results. Companies do this.
Sorry, I’m confused by what you’re saying.
"Aurora is well positioned to achieve positive EBITDA beginning in fiscal Q4 2019 (calendar Q2 2019)."
I read “well-positioned” as they might have achieved positive (adjusted) EBITDA in fiscal Q4, which is reporting Sept 15 or so.
Why are sure they won’t?
Holler!
I think PR was about 4th qtr end (June 30), and broke down cannabis and non-cannabis revenue:
Combined total is 100-107, cannabis-related is 90-95.